Aby John
Aby John has a total of 1 co-authors. Here are the top co-authors by number of shared publications:
- Elamathi Natarajan
Bioinformatics CRO Scientist, Biotecnika, Bangalore, India
1 shared publication
Latest Publications
- Open Access
- 1 November 2026
- Published by GSC Online Press in World Journal of Advanced Research and Reviews
- Vol. 32 (2) , 1314
PREDICTING HIV DRUG RESISTANCE MUTATIONS: BIOINFORMATIC STRATEGIES, MACHINE-LEARNING MODELS, AND CLINICAL RELEVANCE
HIV-1 is characterised by a high degree of genetic diversity, and it is this diversity that leads to resistance against antiretroviral drugs. Resistance occurs when changes in the viral genome reduce the virus's sensitivity to one or more of the antiretroviral agents. By identifying and predicting the mutations associated with resistance, clinicians and researchers are able to explain why treatment fails, monitor the way in which the virus evolves, and select appropriate treatment regimens. Traditional genotypic interpretation makes use of established mutation patterns and scoring systems in order to estimate susceptibility. More recently, progress in the fields of bioinformatics and machine learning has expanded the range of methods available for deducing resistance from viral sequences, the methods extending from statistical regression and support vector machines to random forests, gradient boosting and deep neural networks. Resources that are openly available, especially the Stanford HIV Drug Resistance Database, provide paired genotype and phenotype records which enable model building and benchmarking. Yet, despite this, it is still very difficult to make reliable predictions, due to the diversity of viruses, the effect of interacting mutations, imbalanced class distributions, inconsistent definitions of resistance, and the lack of independently validated data. This review addresses the biology of HIV drug resistance, the existing interpretation tools, computational prediction methods, evaluation practices, and the open problems, and looks at how interpretable and widely applicable systems might be developed. The use of computational models together with established interpretation systems and appropriate clinical evidence could make resistance assessment more reliable.
- 1 November 2026
- Published by GSC Online Press in World Journal of Advanced Research and Reviews
- Vol. 32 (2) , 1314
Open AccessPREDICTING HIV DRUG RESISTANCE MUTATIONS: BIOINFORMATIC STRATEGIES, MACHINE-LEARNING MODELS, AND CLINICAL RELEVANCE
HIV-1 is characterised by a high degree of genetic diversity, and it is this diversity that leads to resistance against antiretroviral drugs. Resistance occurs when changes in the viral genome reduce the virus's sensitivity to one or more of the antiretroviral agents. By identifying and predicting the mutations associated with resistance, clinicians and researchers are able to explain why treatment fails, monitor the way in which the virus evolves, and select appropriate treatment regimens. Traditional genotypic interpretation makes use of established mutation patterns and scoring systems in order to estimate susceptibility. More recently, progress in the fields of bioinformatics and machine learning has expanded the range of methods available for deducing resistance from viral sequences, the methods extending from statistical regression and support vector machines to random forests, gradient boosting and deep neural networks. Resources that are openly available, especially the Stanford HIV Drug Resistance Database, provide paired genotype and phenotype records which enable model building and benchmarking. Yet, despite this, it is still very difficult to make reliable predictions, due to the diversity of viruses, the effect of interacting mutations, imbalanced class distributions, inconsistent definitions of resistance, and the lack of independently validated data. This review addresses the biology of HIV drug resistance, the existing interpretation tools, computational prediction methods, evaluation practices, and the open problems, and looks at how interpretable and widely applicable systems might be developed. The use of computational models together with established interpretation systems and appropriate clinical evidence could make resistance assessment more reliable.